Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Durable Clinical Benefit With KER-050 (Elritercept) Treatment in a Ph2 Study in Patients With Lower-Risk MDS"
By
Insights from 2023 ASH Annual Meeting
FEATURING
Maria Diez-Campelo
By
Insights from 2023 ASH Annual Meeting
FEATURING
Maria Diez-Campelo
Login to view comments.
Click here to Login